Skip to main content
BHC logo

BHC

Bausch Health Companies Inc.

$8.22

3.91%

Trade Ideas Performance

Latest Closed Trade Idea

$8.22

3.91%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

14

Social

13

About

Events of Bausch Health Companies Inc. (BHC)

In the past six months (May-November 2026), Bausch Health reported strong Q3 2026 earnings, beating expectations and raising its full-year outlook due to growth across all segments. Following this, analysts like Jefferies and Royal Bank of Canada adjusted their price targets upwards. Bausch + Lomb appointed Thomas J. Appio as interim CEO. The company anticipates Q4 headwinds for its XIFAXAN product line due to gross-to-net accrual adjustments and channel inventory normalization. A $50 million share repurchase program was announced to offset dilution from management equity awards. As of early November 2026, BHC's stock was trading near the top of its 52-week range ($4.33-$9.04).

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)